Danish EQ-5D-5L value set

The Danish EQ-5D-5L value set have been published by Elgaard Jensen et al. [1].  

As of 2021, the Danish Medicines Council (DMC) have implemented the use of QALYs as the preferred outcome measure of the cost-effectiveness analyses. When possible, this value set should be used to estimate utility values, according to the DMC guidelines. [2] 

NHTA can support you with the calculation of Danish utility values from EQ-5D-5L patient reported outcomes data, ensuring that you application comply with the requirements.


[1]. Jensen, C.E., Sørensen, S.S., Gudex, C. et al. The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data. Appl Health Econ Health Policy (2021). https://doi.org/10.1007/s40258-021-00639-3  

[2]. Medicinrådet, Medicinrådets metodevejledning for vurdering af nye lægemidler (2020). https://medicinraadet.dk/media/qg4jfvk1/medicinr%C3%A5dets_metodevejledning_for_vurdering_af_nye_l%C3%A6gemidler-vers-_1-1_februar_adlegacy.pdf